520 related articles for article (PubMed ID: 26876299)
1. The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.
Li C; Ge Y; Dworkin L; Peng A; Gong R
J Pathol; 2016 May; 239(1):23-35. PubMed ID: 26876299
[TBL] [Abstract][Full Text] [Related]
2. Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.
Bao H; Ge Y; Peng A; Gong R
Kidney Int; 2015 Jun; 87(6):1176-90. PubMed ID: 25629551
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.
Zhou S; Wang P; Qiao Y; Ge Y; Wang Y; Quan S; Yao R; Zhuang S; Wang LJ; Du Y; Liu Z; Gong R
J Am Soc Nephrol; 2016 Aug; 27(8):2289-308. PubMed ID: 26647425
[TBL] [Abstract][Full Text] [Related]
4. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
Li C; Ge Y; Peng A; Gong R
Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W; Ge Y; Liu Z; Gong R
Am J Pathol; 2014 Oct; 184(10):2742-56. PubMed ID: 25239564
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.
Xu W; Ge Y; Liu Z; Gong R
J Biol Chem; 2015 Jan; 290(3):1348-63. PubMed ID: 25468908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
Wang Z; Bao H; Ge Y; Zhuang S; Peng A; Gong R
Br J Pharmacol; 2015 Feb; 172(3):895-909. PubMed ID: 25262943
[TBL] [Abstract][Full Text] [Related]
8. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
9. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
10. Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3β facilitated NFkB activation.
Wang P; Zhou S; Ge Y; Lu M; Liu Z; Gong R
Oncotarget; 2017 Oct; 8(51):88332-88344. PubMed ID: 29179438
[TBL] [Abstract][Full Text] [Related]
11. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
13. Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling.
Lu M; Wang P; Ge Y; Dworkin L; Brem A; Liu Z; Gong R
Sci Rep; 2018 Aug; 8(1):12225. PubMed ID: 30111886
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
17. Reduced LRP6 expression and increase in the interaction of GSK3β with p53 contribute to podocyte apoptosis in diabetes mellitus and are prevented by green tea.
Peixoto EB; Papadimitriou A; Teixeira DA; Montemurro C; Duarte DA; Silva KC; Joazeiro PP; Lopes de Faria JM; Lopes de Faria JB
J Nutr Biochem; 2015 Apr; 26(4):416-30. PubMed ID: 25655048
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
19. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
[TBL] [Abstract][Full Text] [Related]
20. HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration.
Zhang C; Hou B; Yu S; Chen Q; Zhang N; Li H
Biochim Biophys Acta; 2016 Nov; 1863(11):2690-2699. PubMed ID: 27526674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
